NCT05404763View on ClinicalTrials.gov

Mepolizumab and Physical Activity in Severe Asthma

RecruitingOBSERVATIONAL
Enrollment

102

Participants

Timeline

Start Date

February 2, 2023

Primary Completion Date

February 2, 2025

Study Completion Date

July 2, 2025

Conditions
AsthmaAsthma; Eosinophilic
Trial Locations (1)

Unknown

RECRUITING

Lille University Hospital, Lille

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

University Hospital, Lille

OTHER